Mining and analysis of risperidone adverse event signals based on FAERS database
- VernacularTitle:基于美国FAERS数据库的利培酮不良事件信号挖掘与分析
- Author:
Ling HUANG
1
;
Fengling WANG
1
;
Li CHEN
1
;
Xinming WANG
1
;
Li CHEN
1
Author Information
1. Dept. of Pharmacy，the First Affiliated Hospital of Chengdu Medical College，Chengdu 610500，China
- Publication Type:Journal Article
- Keywords:
risperidone;
adverse drug events;
signal;
data mining;
adverse drug reaction
- From:
China Pharmacy
2023;34(3):350-354
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide reference for safe use of risperidone in clinic. METHODS Data mining and analysis of risperidone-related adverse drug event （ADE） reports from the first quarter of 2017 to the third quarter of 2021 in the United States FAERS database were carried out using reported odds ratio and composite criteria methods from Medicines and Healthcare Products Regulatory Agency. RESULTS There were 101 181 ADE reports with risperidone as the primary suspect drug，involving a total of 33 179 patients. Among those reports，the male-to-female ratio was about 6.21 to 1； most of them were ＜18 years old （15.01%）； ADE was mainly reported by consumers （69.74%） and mainly reported by the United States （79.72%）； oral dosage form was the most used，accounting for 83.71%. A total of 409 ADE signals were obtained，including male breast development， pseudogynecomastia，abnormal increase in body mass，hyperprolactinemia and Wellens syndrome，etc. Twenty-six systems and organs were involved，mainly including reproductive system and breast diseases，various injuries，poisoning and operational complications， mental diseases，metabolic and nutritional diseases，and various nervous system diseases，etc. CONCLUSIONS The common ADE signals of risperidone and the system involved are consistent with the instructions，but we should also be alert to the ADE not recorded in the instruction，such as Wellens syndrome，fibroproliferative endocarditis，cavernous degeneration of portal vein，rabbit syndrome，etc.
